Stay Updated
For all press requests, please reach out to [email protected].
Press Releases
New P4AD Analysis: Pharma Hikes Prices on Cancer Drugs, While Lobbying to Obstruct Reform
Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — Patients For Affordable Drugs released a new analysis showing that drugmakers are raising prices on lifesaving oncology medications while lobbying to delay Medicare Drug Price Negotiation programs — reinforcing a pattern of price hikes alongside efforts to weaken reforms. In the […]
Press Releases
Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — Patients For Affordable Drugs is releasing a new analysis finding that pharmaceutical companies raised prices on rare disease drugs just a few months after the passage of the ORPHAN Cures Act in the 2025 Reconciliation Package, which weakened […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) filed its sixth patient-centered amicus brief defending the Medicare Negotiation Program, this time in the District of Columbia U.S. Court of Appeals, where Teva Pharmaceuticals is appealing its failed attempt to strike down the program. The brief underscores the real-world impact of lower prices for patients and responds to legal […]
Reports
Big Pharma Hikes Prices on Rare Disease Drugs - As Medicare Protections are Weakened
Patients For Affordable Drugs is released a new analysis finding that pharmaceutical companies raised prices on rare disease drugs just a few months after the passage of the ORPHAN Cures Act in the 2025 Reconciliation Package. Click here to download
Reports
Big Pharma Hikes Cancer Drugs for Americans
As Americans face growing anxiety about their ability to pay for health care in 2026, pharmaceutical corporations continue to raise prices on some of the most expensive drugs on the market: cancer treatments Click here to download
Reports
How Pharma Price Hikes and the EPIC Act Threaten Access to Lifesaving HIV Treatment
A new analysis from Patients For Affordable Drugs spotlights a troubling pattern: pharmaceutical companies are raising prices on HIV medications, while simultaneously lobbying Congress to pass the harmful EPIC Act. Click here to download
Press Releases
Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — A new analysis from Patients For Affordable Drugs spotlights a troubling pattern: pharmaceutical companies are raising prices on HIV medications, while simultaneously lobbying Congress to pass the harmful EPIC Act, which would delay Medicare drug price negotiations that could lower prices on […]
Press Releases
ICYMI: Majority of Americans Worried about Affording Prescription Drugs, New Polling Confirms
WASHINGTON, D.C. — New polling from KFF underscores just how deeply the high cost of prescription drugs is harming Americans across the country. Findings include: 59% of U.S. adults are worried about their ability to pay for prescription drugs, either for themselves or their families. This is the largest share since KFF began polling the question in 2018. […]